论文信息 - Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer - 字舞流文

Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer

M. Birrer | R. Kerbel | S. Eliasof | U. Matulonis | Christina R. Lee | S. Man | Elizabeth Pham | P. Xu | C. Krasner | D. Lazarus | Christian G Peters | C. Peters | E. Garmey